Research programme: hERG channel activators - NeuroSearchAlternative Names: NS1463
Latest Information Update: 28 Sep 2011
At a glance
- Originator NeuroSearch
- Mechanism of Action Potassium channel modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 28 Sep 2011 Discontinued - Preclinical for Arrhythmias in Denmark (unspecified route)
- 16 Aug 2006 Preclinical trials in Arrhythmias in Denmark (unspecified route)